This recent Applied Clinical Trials article discusses ICON's acquisition of majority shareholding in MeDiNova Research, a site network with research sites in Europe and Africa, granting our company the right to acquire the remaining shares in the company by the third quarter of 2020. MeDiNova Research currently has a network of 33 active clinical research sites in the UK, Spain, South Africa, Poland and Romania.

View Article